Description
Release form
Capsules with powder for inhalation.
Packing
30 pcs
Pharmacological action
Beta-adrenergic stimulant, with selectivity for beta2-adrenergic receptors of smooth muscles of the bronchi, has a bronchodilator effect. Foradil is effective for the prevention and relief of bronchospasm caused by allergens, physical activity, histamine, methacholine (diagnostic test). Foradil has tocolytic properties. The onset of action is 1-3 minutes after inhalation, the duration of the bronchodilator effect is 12 hours.
Indications
Relief and prevention of reversible airway obstruction – COPD, bronchial asthma (including atopic and physical activity asthma).
Contraindications
Hypersensitivity, children (up to 5 years). With caution. Diabetes mellitus, expressed CHF, IHD, heart rhythm disturbances, AV block III stage, lengthening of the QT interval (QT adjusted> 0.44 s), GOKMP, thyrotoxicosis, pregnancy, lactation period.
Special instructions
Patients must be trained in the use of an inhaler by a doctor or medical staff. Patients receiving treatment in the form of inhalation of corticosteroids in combination with aerosol should not stop treatment of corticosteroids. Patients with diabetes mellitus are shown control of blood glucose concentration. In patients with severe bronchial asthma, the risk of developing hypokalemia with hypoxia and concomitant therapy increases therefore, they need regular monitoring of K + in serum. The possibility of use in young children depends on the individual ability of the child to use the inhaler correctly (including breathing techniques), used only under the supervision of an adult. Tremor or anxiety during treatment with beta-adrenostimulants may affect the patient ² ¢s ability to drive.
Composition
1 capsule contains formoterol fumarate 12 mcg.
Dosage and administration of
Foradil is administered by inhalation. Adults with bronchospastic syndrome – 12-24 mcg 2 times a day, children 5 years and older – 12 mcg (no more) 2 times a day, if necessary, you can use an additional 1-2 caps. to prevent bronchospasm caused by physical exertion or exposure to a known allergen, inhale 1 dose (12 mcg) about 15 minutes before work or contact with this factor in severe cases of bronchial asthma, 2 doses (24 mcg) may be inhaled.
Side effects
Adverse reactions are distributed according to the frequency of occurrence. The following criteria were used to estimate the frequency: very often (? 10%) often (? 1%, Allergic reactions: very rarely – hypersensitivity reactions such as arterial hypotension, urticaria, angioedema, itching, exanthema.
From the side of the central nervous system: often – headache, tremor sometimes – agitation, anxiety, nervousness, insomnia, dizziness.
From the cardiovascular system: often – palpitations sometimes – tachycardia is very rare – peripheral edema.
From the respiratory system: sometimes – bronchospasm.
From the digestive system: very rarely – nausea is a distortion of taste.
From the musculoskeletal system: sometimes – muscle cramps, myalgia.
Local reactions: sometimes – irritation of the mucous membrane of the pharynx and larynx.
Drug interactions
drugs with adreno-stimulating activity, MAO inhibitors, tricyclic antidepressants increase the risk of side effects from CCC. Xanthine derivatives, corticosteroids, diuretics increase the likelihood of hypokalemia of the drug. Quinidine, disopyramide, procainamide, phenothiazines, antihistamines, tricyclic antidepressants increase the risk of ventricular arrhythmias. Beta-blockers (including in the form of eye drops) partially or completely block the action.
Overdose
Symptoms: nausea, vomiting, headache, tremor, drowsiness, ventricular arrhythmia, decreased blood pressure, metabolic acidosis, hypokalemia, hyperglycemia.
Treatment: symptomatic.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
active substance
Formoterol
Pharmacy terms
Prescription
lekarstvennaja form
kapsul
Appointment
As prescribed for the doctor, As prescribed by the doctor over 5 years old
Novartis Farma Stein AG, Switzerland
